Search

Your search keyword '"Rodriguez, Lauren"' showing total 45 results

Search Constraints

Start Over You searched for: Author "Rodriguez, Lauren" Remove constraint Author: "Rodriguez, Lauren" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
45 results on '"Rodriguez, Lauren"'

Search Results

1. Immediate myeloid depot for SARS-CoV-2 in the human lung

2. SARS-CoV-2 infection of airway organoids reveals conserved use of Tetraspanin-8 by Ancestral, Delta, and Omicron variants

3. COVID-19–associated Lung Microvascular Endotheliopathy: A “From the Bench” Perspective

4. The Type 2 Asthma Mediator IL-13 Inhibits Severe Acute Respiratory Syndrome Coronavirus 2 Infection of Bronchial Epithelium

5. Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study

8. Comparing the efficiency of DNA extraction protocols across a multinational environmental DNA initiative

11. Irish Para Report Card on Physical Activity of Children and Adolescents With Disabilities.

12. Three Lessons Learned About Power and Improving Recruitment of Underrepresented Populations in Clinical Trials.

13. NF-κB inhibitor alpha controls SARS-CoV-2 infection in ACE2-overexpressing human airway organoids.

15. No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials

18. Remdesivir for COVID-19 in Hospitalized Children: A Phase 2/3 Study.

19. Discovery of GS-5245 (Obeldesivir), an Oral Prodrug of Nucleoside GS-441524 That Exhibits Antiviral Efficacy in SARS-CoV-2-Infected African Green Monkeys

20. Viral Resistance Analyses From the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1)

26. Assessing vertebrate biodiversity across the Chesapeake Bay using environmental DNA metabarcoding

27. 1149. Resistance Analyses of Patient Viral Samples from the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1)

28. NF-κB inhibitor alpha has a cross-variant role during SARS-CoV-2 infection in ACE2-overexpressing human airway organoids

29. Remdesivir and GS-441524 Retain Antiviral Activity against Delta, Omicron, and Other Emergent SARS-CoV-2 Variants

30. Immediate myeloid depot for SARS-CoV-2 in the human lung

33. SARS-CoV-2 Infection of Lung Organoids Reveals Conserved Use of Tetraspanin-8 by Ancestral-, Delta-, and Omicron- Variants

34. List of contributors

35. The Type 2 Asthma Mediator IL-13 Inhibits SARS-CoV-2 Infection of Bronchial Epithelium.

36. Factors associated with changes in consumption among smokers and alcohol drinkers during the COVID-19 'lockdown' period.

37. Lake networks and connectivity metrics for the conterminous U.S. (LAGOS‐US NETWORKS v1).

38. LAGOS‐US LOCUS v1.0: Data module of location, identifiers, and physical characteristics of lakes and their watersheds in the conterminous U.S.

39. The use and Impact of Self-Monitoring on Substance use Outcomes: A Descriptive Systematic Review

43. Associations among military sexual trauma, positive alcohol expectancies, and coping behaviors in female veterans.

44. NF-κB inhibitor alpha has a cross-variant role during SARS-CoV-2 infection in ACE2-overexpressing human airway organoids.

45. Immediate myeloid depot for SARS-CoV-2 in the human lung.

Catalog

Books, media, physical & digital resources